PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System

Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.465
https://www.valueinhealthjournal.com/article/S1098-3015(21)00682-3/fulltext
Section Title :
Section Order : 11025
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00682-3&doi=10.1016/j.jval.2021.04.465
HEOR Topics :
Tags :
Regions :